Straits Times Index
3,323.38 +0.18 (+0.01%) S&P 500
5,241.69 -25.26 (-0.48%) Dow
38,055.10 -386.44 (-1.01%) Nasdaq
16,836.19 -84.39 (-0.50%) Bitcoin USD
68,454.42 +991.09 (+1.47%) CMC Crypto 200
1,432.54 -23.33 (-1.60%)
LLY Jul 2024 610.000 put
- Benzinga
FDA Conditionally Approves Eli Lilly's Thyroid Cancer Drug For Pediatric Patients With Certain Mutations
Wednesday, the FDA granted accelerated approval to Eli Lilly And Co’s (NYSE:LLY) selpercatinib (Retevmo) for pediatric patients two years of age and older with the following: Advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, who require systemic therapy. Advanced or metastatic thyroid cancer with a RET gene fusion, who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate). Locally advanced or metastatic solid tumors wit
- PR Newswire
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
During the World Health Assembly today, Eli Lilly and Company (NYSE: LLY) announced it will donate $6.5 million to the United States Fund for UNICEF to expand UNICEF's work to improve the health outcomes of millions of children and youth at risk of noncommunicable diseases (NCDs) living in resource-limited settings in India. This will bring the company's total commitment since 2022 to more than $20 million.
- PR Newswire
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024. Patrik Jonsson, executive vice president, president of Lilly Diabetes and Obesity, and president of Lilly USA, will participate in a fireside chat at 4 p.m. Eastern time.
